Burney Company’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,666
Closed -$203K 623
2023
Q4
$203K Buy
+1,666
New +$186K 0.01% 564
2023
Q3
Sell
-1,674
Closed -$244K 598
2023
Q2
$244K Sell
1,674
-20
-1% -$2.72K 0.01% 518
2023
Q1
$219K Sell
1,694
-10
-0.6% -$1.26K 0.01% 530
2022
Q4
$217K Buy
+1,704
New +$198K 0.01% 515
2022
Q2
Sell
-1,688
Closed -$216K 584
2022
Q1
$216K Sell
1,688
-51
-3% -$6.15K 0.01% 553
2021
Q4
$214K Buy
1,739
+38
+2% +$4.97K 0.01% 561
2021
Q3
$242K Hold
1,701
0.01% 526
2021
Q2
$266K Hold
1,701
0.01% 519
2021
Q1
$264K Sell
1,701
-31
-2% -$4.8K 0.01% 499
2020
Q4
$259K Buy
1,732
+177
+11% +$25K 0.01% 459
2020
Q3
$206K Buy
+1,555
New +$203K 0.01% 477
2020
Q1
Sell
-1,408
Closed -$205K 485
2019
Q4
$205K Buy
+1,408
New +$194K 0.01% 448

Other funds holding ZBH

Burney Company's ZBH Position: Q1 2024 in Review

Burney Company sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 1,666 shares — an estimated $203K sold.

Burney Company first reported a position in ZBH in Q4 2019 and held it in 12 quarters. The position peaked at $266K in Q2 2021. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Burney Company reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Burney Company sold 1,666 Zimmer Biomet shares in Q1 2024, an estimated $203K.
  • Burney Company first reported a position in Zimmer Biomet in Q4 2019 and held it in 12 quarters.
  • Burney Company's Zimmer Biomet position peaked at $266K in Q2 2021.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Burney Company's 13F filing for Q1 2024, filed 22 May 2024.